Journal of Surgery Concepts & Practice››2022,Vol. 27››Issue (02): 93-94.doi:10.16139/j.1007-9610.2022.02.001
• Editorial •Next Articles
TANG Zhaoyou(
)
Received:2021-12-01Online:2022-05-25Published:2022-06-16Contact:TANG Zhaoyou E-mail:zytang88@163.comCLC Number:
TANG Zhaoyou. Enlightenment of Chinese philosophic thinking on treatment of liver cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 93-94.
| [1] | Kelley RK. Atezolizumab plus bevacizumab—a landmark in liver cancer[J]. N Engl J Med, 2020, 382(20):1953-1955. doi:10.1056/NEJMe2004851URL |
| [2] | Zahalka AH, Frenette PS. Nerves in cancer[J]. Nat Rev Cancer, 2020, 20(3):143-157. doi:10.1038/s41568-019-0237-2pmid:31974491 |
| [3] | Gao X, Sanderson SM, Dai Z, et al. Dietary methionine influences therapy in mouse cancer models and alters human metabolism[J]. Nature, 2019, 572(7769):397-401. doi:10.1038/s41586-019-1437-3URL |
| [4] | Kanarek N, Petrova B, Sabatini DM. Dietary modifications for enhanced cancer therapy[J]. Nature, 2020, 579(7800):507-517. doi:10.1038/s41586-020-2124-0URL |
| [5] | Saeb-Parsy K, Wynn TA, Vallier L, et al. Plant-based and animal-based low-carbohydrate diets and risk of he-patocellular carcinoma among US men and women[J]. Hepatology, 2021, 73(1):175-185. doi:10.1002/hep.31251URL |
| [6] | Zhang KZ, Zhang QB, Zhang QB, et al. Arsenic trioxide induces differentiation of CD133+hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model[J]. J Hematol Oncol, 2014, 7:28. doi:10.1186/1756-8722-7-28URL |
| [7] | Loh SN. Arsenic and an old place: rescuing p53 mutants in cancer[J]. Cancer Cell, 2021, 39(2):140-142. doi:10.1016/j.ccell.2021.01.012URL |
| [8] | Liao SF, Koshiol J, Huang YH, et al. Postdiagnosis aspirin use associated with decreased biliary tract cancer-specific mortality in a large nationwide cohort[J]. He-patology, 2021, 74(4):1994-2006. |
| [9] | Choi J, Jo C, Lim YS. Tenofovirversusentecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection[J]. Hepatology, 2021, 73(2):661-673. doi:10.1002/hep.31289URL |
| [10] | Goh MJ, Sinn DH, Kim S, et al. Statin use and the risk of hepatocellular carcinoma in patients with chronic he-patitis B[J]. Hepatology, 2020, 71(6):2023-2032. doi:10.1002/hep.30973URL |
| [11] | Prasad V. Our best weapons against cancer are not magic bullets[J]. Nature, 2020, 577(7791):451. doi:10.1038/d41586-020-00116-2URL |
| [12] | Zheng H, Pomyen Y, Hernandez MO, et al. Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma[J]. Hepatology, 2018, 68(1):127-140. doi:10.1002/hep.29778URL |
| [1] | YE Feng, GONG Xiaoyong, REN Jiajun, CAI Qiang, CHEN Sheng.Application of ERCP in diagnosis and treatment of biliary complications during perioperative period of primary liver cancer[J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 355-360. |
| [2] | CHANG Jessica, CHEN Xuxiao, CHEN Yongjun.Role of the spleen in patients with liver cancer and cirrhosis[J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 394-398. |
| [3] | ZHANG Hui, GONG Ling, GUO Qian, LUO Yan.Retrospective study on sugammadex for reversal of neuromuscular blockade after radiofrequency ablation of hepatic carcinoma under general anesthesia[J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 72-76. |
| [4] | ZHANG Jixiang, XIE Zhihua, LI Wei, JIANG Xiaoqing.Classification of intrahepatic cholangiocarcinoma and hot topics in surgical treatment[J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 478-482. |
| [5] | YIN Yanjiang, LUO Zhiwen, CHEN Xiao, ZHANG Yefan, HUANG Zhen, ZHAO Hong, ZHAO Jianjun, LI Zhiyu, ZHOU Jianguo, CAI Jianqiang, BI Xinyu.Relationship between surgical margin and prognosis of patients with intrahepatic cholangiocarcinoma[J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 221-228. |
| [6] | CHEN Congyan, WANG Junqing, CHEN Yongjun.Gut microbiota and mechanism of liver cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 256-260. |
| [7] | REN Jiajun, CHEN Yongjun.Simultaneous hepatectomy and splenectomy in treatment of portal hypertension and hypersplenism complicated by primary liver cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 139-144. |
| [8] | SUN Huichuan.Current status and perspectives of conversion therapy for hepatocellular carcinoma[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 134-138. |
| [9] | MA Jingqin, YANG Minjie, YAN Zhiping.Precision transarterial chemoembolization: treatment goal and embolic endpoint[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 131-133. |
| [10] | BAO Quan, XING Baocai.Surgical treatment strategy for complex bilateral multiple liver metastases of colorectal carcinoma[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 128-130. |
| [11] | CAO Jun, CHEN Yajin.Laparoscopic anatomic hepatectomy in treatment of hepatocellular carcinoma: standardization and think deeply[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 123-127. |
| [12] | FENG Hao, LÜ Zicheng, XIA Qiang.Liver transplantation in treatment of hepatocellular carcinoma: management of whole⁃process and progress in treatment[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 119-122. |
| [13] | HUANG Jiwei, QIU Guoteng, ZENG Yong.Advances in surgical treatment of hepatocellular carcinoma[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 113-118. |
| [14] | FANG Cheng, XIA Yong, WANG Kui, SHEN Feng.Conversion therapy for intrahepatic cholangiocarcinoma: status and perspectives[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 107-112. |
| [15] | LIU Shenyang, TANG Zhaohui, QUAN Zhiwei.Advances in surgical treatment of intrahepatic cholangiocarcinoma[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 100-106. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
